Download PDF
Dtsch Med Wochenschr 2017; 142(04): 267-274
DOI: 10.1055/s-0042-110193
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

Mikrobielle Biomarker zur Krebsfrüherkennung

Microbial Biomarkers for Early Cancer Detection
Anita Y. Voigt
,
Georg Zeller
,
Peer Bork
Further Information

Publication History

Publication Date:
24 February 2017 (online)

Also available at
    Permissions and Reprints

Abstract

The human microbiome – the vast amount of microbes that colonize our body – play an important role in maintaining our health. Changes in microbiome composition have been linked to multiple diseases including cancer. Although mechanisms and causalities of these associations still have to be uncovered, microbiome alterations across various stages of disease can be utilized for novel diagnostic and prognostic tests. Research on biomarkers extracted from the gut microbiome has in particular focused on colorectal cancer, where clinical use is already on the horizon. For example, multiple microbial taxonomic markers such as Fusobacterium nucleatum and other oral pathogens have been identified in human feces with potential for non-invasive diagnostics and prognostics. The article summarizes the recent developments, but also limitations and challenges for the development of microbiome-based biomarkers for cancer early detection.

Im Bereich Krebsfrüherkennung zeigt sich schon heute das Potential der Mikrobiomforschung für klinische Anwendungen. Auch wenn die zugrunde liegenden Mechanismen und Ursachen bisher weitgehend unbekannt sind, kann die krankheitsbedingte Veränderung des Mikrobioms als Angriffspunkt zur Erforschung neuartiger diagnostischer und prognostischer Tests genutzt werden. Dies trifft insbesondere auf Dickdarmkrebs zu, wo sich bereits konkrete Möglichkeiten für den klinischen Einsatz abzeichnen. In diesem Artikel fassen wir die Fortschritte der letzten Jahre aber auch Schwierigkeiten in der Entwicklung mikrobieller Biomarker für die Krebsfrüherkennung zusammen.

Schlüsselwörter

mikrobielle Biomarker - Mikrobiom - Metagenomik - Darmkrebs

Key words

microbial biomarker - microbiome - metagenomics - colon cancer
 

  • Literatur

  • 1 Sender R. Fuchs S. Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol 2016; 14: e1002533
    CrossrefPubMedGoogle Scholar
  • 2 Li J. Jia H. Cai X. et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014; 32: 834-841
    CrossrefPubMedGoogle Scholar
  • 3 Voigt AY. Costea PI. Kultima JR. et al. Temporal and technical variability of human gut metagenomes. Genome Biol 2015; 16: 73
    CrossrefPubMedGoogle Scholar
  • 4 Turnbaugh PJ. Hamady M. Yatsunenko T. et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-484
    CrossrefPubMedGoogle Scholar
  • 5 Schloissnig S. Arumugam M. Sunagawa S. et al. Genomic variation landscape of the human gut microbiome. Nature 2013; 493: 45-50
    PubMedGoogle Scholar
  • 6 Qin J. Li Y. Cai Z. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60
    CrossrefPubMedGoogle Scholar
  • 7 Karlsson FH. Tremaroli V. Nookaew I. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013; 498: 99-103
    CrossrefPubMedGoogle Scholar
  • 8 Forslund K. Hildebrand F. Nielsen T. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015; 528: 262-266
    CrossrefPubMedGoogle Scholar
  • 9 Noguera-Julian M. Rocafort M. Guillen Y. et al. Gut Microbiota Linked to Sexual Preference and HIV Infection. EBioMedicine 2016; 5: 135-146
    CrossrefPubMedGoogle Scholar
  • 10 Le Chatelier E. Nielsen T. Qin J. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500: 541-546
    CrossrefPubMedGoogle Scholar
  • 11 Qin N. Yang F. Li A. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513: 59-64
    CrossrefPubMedGoogle Scholar
  • 12 Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis 2013; 34: 2193-2197
    CrossrefPubMedGoogle Scholar
  • 13 Gao S. Li S. Ma Z. et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer 2016; 11: 3
    CrossrefPubMedGoogle Scholar
  • 14 Kullander J. Forslund O. Dillner J. Staphylococcus aureus and squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 2009; 18: 472-478
    CrossrefPubMedGoogle Scholar
  • 15 Castellarin M. Warren RL. Freeman JD. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306
    CrossrefPubMedGoogle Scholar
  • 16 Flanagan L. Schmid J. Ebert M. et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis 2014; 33: 1381-1390
    CrossrefPubMedGoogle Scholar
  • 17 Kostic AD. Chun E. Robertson L. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell host & microbe 2013; 14: 207-215
    CrossrefPubMedGoogle Scholar
  • 18 Kostic AD. Gevers D. Pedamallu CS. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-298
    CrossrefPubMedGoogle Scholar
  • 19 Zeller G. Tap J. Voigt AY. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014; 10: 766
    CrossrefPubMedGoogle Scholar
  • 20 Rubinstein MR. Wang X. Liu W. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell host & microbe 2013; 14: 195-206
    CrossrefPubMedGoogle Scholar
  • 21 Arthur JC. Gharaibeh RZ. Muhlbauer M. et al. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat Commun 2014; 5: 4724
    CrossrefPubMedGoogle Scholar
  • 22 Cuevas-Ramos G. Petit CR. Marcq I. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 2010; 107: 11537-11542
    CrossrefPubMedGoogle Scholar
  • 23 Goodwin AC. Destefano Shields CE. Wu S. et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A 2011; 108: 15354-15359
    CrossrefPubMedGoogle Scholar
  • 24 Toprak NU. Yagci A. Gulluoglu BM. et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006; 12: 782-786
    CrossrefPubMedGoogle Scholar
  • 25 National Cancer Institute. Helicobacter pylori and Cancer. Im Internet: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/h-pylori-fact-sheet-q3 Stand: 04.12.2016
    PubMedGoogle Scholar
  • 26 Koeth RA. Wang Z. Levison BS. et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19: 576-585
    CrossrefPubMedGoogle Scholar
  • 27 Wang Z. Klipfell E. Bennett BJ. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63
    CrossrefPubMedGoogle Scholar
  • 28 Weir TL. Manter DK. Sheflin AM. et al. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 2013; 8: e70803
    CrossrefPubMedGoogle Scholar
  • 29 Wu S. Rhee KJ. Albesiano E. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15: 1016-1022
    CrossrefPubMedGoogle Scholar
  • 30 Feng Q. Liang S. Jia H. et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 2015; 6: 6528
    CrossrefPubMedGoogle Scholar
  • 31 Yu J. Feng Q. Wong SH. et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 2015; pii: gutjnl-2015-309800 DOI: 10.1136/gutjnl-2015-309800.
    CrossrefPubMedGoogle Scholar
  • 32 Baxter NT. Ruffin 4th MT. Rogers MA. et al. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med 2016; 8: 37
    CrossrefPubMedGoogle Scholar
  • 33 Vogtmann E. Hua X. Zeller G. et al. Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLoS One 2016; 11: e0155362
    CrossrefPubMedGoogle Scholar
  • 34 Wang T. Cai G. Qiu Y. et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012; 6: 320-329
    CrossrefPubMedGoogle Scholar
  • 35 Zackular JP. Rogers MA. Ruffin 4th MT. et al. The Human Gut Microbiome as a Screening Tool for Colorectal Cancer. Cancer Prev Res (Phila) 2014; 7: 1112-1121
    CrossrefPubMedGoogle Scholar
  • 36 Iida N. Dzutsev A. Stewart CA. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013; 342: 967-970
    CrossrefPubMedGoogle Scholar
  • 37 Viaud S. Saccheri F. Mignot G. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013; 342: 971-976
    CrossrefPubMedGoogle Scholar
  • 38 Jameson JL. Longo DL. Precision medicine--personalized, problematic, and promising. N Engl J Med 2015; 372: 2229-2234
    CrossrefPubMedGoogle Scholar
  • 39 van Nood E. Vrieze A. Nieuwdorp M. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415
    CrossrefPubMedGoogle Scholar
  • 40 Li SS. Zhu A. Benes V. et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 2016; 352: 586-589
    CrossrefPubMedGoogle Scholar
  • 41 Mima K. Nishihara R. Qian ZR. et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 2015; pii: gutjnl-2015-310101 DOI: 10.1136/gutjnl-2015-310101.
    CrossrefPubMedGoogle Scholar
  • 42 Ito M. Kanno S. Nosho K. et al. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int J Cancer 2015; 137: 1258-1268
    CrossrefPubMedGoogle Scholar
  • 43 Yu J. Chen Y. Fu X. et al. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int J Cancer 2016; 139: 1318-1326
    CrossrefPubMedGoogle Scholar
  • 44 Mima K. Sukawa Y. Nishihara R. et al. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol 2015; 1: 653-661
    CrossrefPubMedGoogle Scholar
  • 45 Goodwin AC. Destefano Shields CE. Wu S. et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA 2011; 108: 15354-15359
    CrossrefPubMedGoogle Scholar
  • 46 Inaba H. Sugita H. Kuboniwa M. et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol 2014; 16: 131-145
    CrossrefPubMedGoogle Scholar
  • 47 Urbaniak C. Gloor GB. Brackstone M. et al. The Microbiota of Breast Tissue and Its Association with Breast Cancer. Appl Environ Microbiol 2016; 82: 5039-5048
    CrossrefPubMedGoogle Scholar
  • 48 Nagaraja V. Eslick GD. Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther 2014; 39: 745-750
    CrossrefPubMedGoogle Scholar
  • 49 Hua-Feng X. Yue-Ming W. Hong L. et al. A meta-analysis of the association between Chlamydia pneumoniae infection and lung cancer risk. Indian J Cancer 2015; 52 (Suppl. 02) e112-e115
    CrossrefPubMedGoogle Scholar
  • 50 Wroblewski LE. Peek Jr RM. Helicobacter pylori, Cancer, and the Gastric Microbiota. Adv Exp Med Biol 2016; 908: 393-408
    PubMedGoogle Scholar